Sitagliptin vs Latanoprost: side-by-side comparison
Sitagliptin (DPP-4 inhibitor) and Latanoprost (Prostaglandin analogue) belong to different therapeutic classes and are rarely substitutes for each other. The comparison is useful when a single patient is weighing both options for adjacent or overlapping needs.
| Property | Sitagliptin | Latanoprost |
|---|---|---|
| Therapeutic class | DPP-4 inhibitor | Prostaglandin analogue |
| CAS | 486460-32-6 | 130209-82-4 |
| ATC | A10BH01 | S01EE01 |
| Molecular weight | 407.31 g/mol | 432.59 g/mol |
| Brands with this active ingredient | 1 | 1 |
What they share
Sitagliptin and Latanoprost share the common regulatory framework for prescription active ingredients, bioequivalence standards for generics, and pharmacist oversight. Beyond that, points in common are limited.
Key differences
Sitagliptin acts by a different mechanism than Latanoprost, with indications that barely overlap. Comparing the two is useful when a clinician has mentioned both in the same context or the patient wants to understand why one was prescribed instead of the other.
Mechanisms compared
Sitagliptin: Sitagliptin hemmt reversibel DPP-4, die Serinprotease, die für den schnellen Abbau von Glucagon-like Peptid 1 (GLP-1) und glukoseabhängigem insulinotropen Polypeptid (GIP) verantwortlich ist. Latanoprost: Latanoprost ist ein Prodrug-Ester, der durch Hornhautesterasen zur aktiven freien Säure hydrolysiert wird, die selektiv an den Prostaglandin-F-Rezeptor (FP) bindet.
Indications compared
Sitagliptin: Sitagliptin ist bei Erwachsenen mit Typ-2-Diabetes mellitus, allein oder in Kombination mit anderen antidiabetischen Wirkstoffen, zur Verbesserung der glykämischen Kontrolle zugelassen. Latanoprost: Latanoprost ist bei Erwachsenen und Kindern zur Behandlung der okulären Hypertension und des chronischen Offenwinkelglaukoms zugelassen.
Safety profile
Sitagliptin: Sitagliptin wird im Allgemeinen gut vertragen. Latanoprost: Häufige Nebenwirkungen sind konjunktivale Hyperämie, okuläre Reizung, Wimpernwachstum und -verdunkelung sowie eine fortschreitende Irispigmentierung, die dauerhaft ist.
Häufig gestellte Fragen
Is Sitagliptin better than Latanoprost? ▾
Sitagliptin and Latanoprost are not "better or worse" — they treat different things. The sensible question is which fits your specific need.
Can Sitagliptin and Latanoprost be combined? ▾
Whether they can be combined depends on the indications and the interaction profile of each. If both are in a single prescription, the prescriber has weighed it; in self-medication they should never be combined.
Do they have the same side-effect profile? ▾
No — they belong to different classes and have distinct side-effect profiles. Each has its own prescribing information.
Products with Sitagliptin
Products with Latanoprost
Die Informationen auf dieser Website dienen ausschließlich zu Referenz- und Bildungszwecken. Sie ersetzen nicht die Beratung durch qualifiziertes medizinisches Fachpersonal.